Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Net Margin (2016 - 2020)

Historic Net Margin for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q2 2020 value amounting to 224.74%.

  • KalVista Pharmaceuticals' Net Margin rose 1470700.0% to 224.74% in Q2 2020 from the same period last year, while for Jan 2021 it was 224.74%, marking a year-over-year increase of 1228600.0%. This contributed to the annual value of 3171.17% for FY2025, which is 34244500.0% up from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Net Margin stood at 224.74% for Q2 2020, which was up 1470700.0% from 783.26% recorded in Q1 2020.
  • KalVista Pharmaceuticals' Net Margin's 5-year high stood at 13.57% during Q2 2018, with a 5-year trough of 94342.86% in Q1 2016.
  • In the last 5 years, KalVista Pharmaceuticals' Net Margin had a median value of 371.8% in 2019 and averaged 6583.21%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -202857100bps in 2016, then skyrocketed by 49472100bps in 2018.
  • Quarter analysis of 5 years shows KalVista Pharmaceuticals' Net Margin stood at 2152.79% in 2016, then skyrocketed by 79bps to 442.41% in 2017, then soared by 81bps to 83.85% in 2018, then tumbled by -167bps to 224.08% in 2019, then fell by 0bps to 224.74% in 2020.
  • Its Net Margin stands at 224.74% for Q2 2020, versus 783.26% for Q1 2020 and 224.08% for Q4 2019.